PPAT
Amidophosphoribosyltransferase
Also known as: GPAT, PRAT, PUR1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q06203
- Gene
- PPAT
- Ensembl
- ENSG00000128059
- Chromosome
- 4
- Canonical length
- 517 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Midbody ring
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene is a member of the purine/pyrimidine phosphoribosyltransferase family. It is a regulatory allosteric enzyme that catalyzes the first step of de novo purine nucleotide biosythetic pathway. This gene and PAICS/AIRC gene, a bifunctional enzyme catalyzing steps six and seven of this pathway, are located in close proximity on chromosome 4, and divergently transcribed from an intergenic region. [provided by RefSeq, Mar 2011]
Canonical amino-acid sequenceUniProt
517 residues, UniProt reviewed canonical sequence.
>Q06203|PPAT
1 MELEELGIRE ECGVFGCIAS GEWPTQLDVP HVITLGLVGL QHRGQESAGI VTSDGSSVPT
61 FKSHKGMGLV NHVFTEDNLK KLYVSNLGIG HTRYATTGKC ELENCQPFVV ETLHGKIAVA
121 HNGELVNAAR LRKKLLRHGI GLSTSSDSEM ITQLLAYTPP QEQDDTPDWV ARIKNLMKEA
181 PTAYSLLIMH RDVIYAVRDP YGNRPLCIGR LIPVSDINDK EKKTSETEGW VVSSESCSFL
241 SIGARYYREV LPGEIVEISR HNVQTLDIIS RSEGNPVAFC IFEYVYFARP DSMFEDQMVY
301 TVRYRCGQQL AIEAPVDADL VSTVPESATP AALAYAGKCG LPYVEVLCKN RYVGRTFIQP
361 NMRLRQLGVA KKFGVLSDNF KGKRIVLVDD SIVRGNTISP IIKLLKESGA KEVHIRVASP
421 PIKYPCFMGI NIPTKEELIA NKPEFDHLAE YLGANSVVYL SVEGLVSSVQ EGIKFKKQKE
481 KKHDIMIQEN GNGLECFEKS GHCTACLTGK YPVELEWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PPAT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 8.1 nTPM
Expression across tissuesHPA
Tissue
- testis: 8.1 nTPM
- lymph node: 7.8 nTPM
- thymus: 7.7 nTPM
- tonsil: 7.5 nTPM
- breast: 6.7 nTPM
- ovary: 6.7 nTPM
Single-cell type
- erythrocyte progenitors: 69 nCPM
- oocytes: 51 nCPM
- cardiomyocytes: 50 nCPM
- sertoli cells: 49 nCPM
- cytotrophoblasts: 48 nCPM
- differentiating spermatogonia: 48 nCPM
Immune cell
- NK-cell: 10 nTPM
- naive CD4 T-cell: 7.8 nTPM
- memory B-cell: 7.5 nTPM
- naive CD8 T-cell: 7.1 nTPM
- naive B-cell: 6.2 nTPM
- MAIT T-cell: 5.9 nTPM
Brain region
- pons: 7.1 nTPM
- white matter: 6.7 nTPM
- hypothalamus: 6.6 nTPM
- cerebral cortex: 6.5 nTPM
- midbrain: 6.5 nTPM
- thalamus: 6.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.3
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 3.06
- DepMap mean gene effect
- -0.71
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' AMP biosynthetic process
- 'de novo' IMP biosynthetic process
- 'de novo' XMP biosynthetic process
- GMP biosynthetic process
- purine nucleobase biosynthetic process
- purine nucleotide biosynthetic process
Molecular functions
- 4 iron, 4 sulfur cluster binding
- metal ion binding
- amidophosphoribosyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Phosphoribosyltransferase domain
- Glutamine amidotransferase type 2 domain
- Nucleophile aminohydrolases, N-terminal
- Phosphoribosyltransferase-like
- Phosphoribosyl transferase domain
- Glutamine amidotransferase domain
- Amidophosphoribosyltransferase
- Amidophosphoribosyltransferase, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PPAT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PPAT as an antibody target. Whether an autoantibody or antibody against PPAT could matter depends on whether native PPAT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PPAT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PPAT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...